Question

Difficulty: HardMenstrual Cycle Abnormalities and Contraception

A 16-year-old phenotypic female is brought to the gynecology clinic by her mother for evaluation of primary amenorrhea. She has never had a menstrual period. On physical examination, her blood pressure is 110/70 mm Hg, heart rate is 76/min, and BMI is 21 kg/m². Breast development is Tanner stage 4, but axillary and pubic hair are Tanner stage 1. Examination of the external genitalia reveals a normal-appearing clitoris and a shortened vaginal vault. Assuming each successive test or intervention directs the next step according to standard guidelines, arrange the following diagnostic and management steps in the correct chronological sequence to appropriately evaluate and treat this patient.

  1. 1Obtain a urine beta-hCG test
  2. 2Perform a pelvic ultrasonography
  3. 3Measure serum testosterone and obtain a karyotype
  4. 4Perform bilateral laparoscopic gonadectomy
  5. 5Initiate estrogen replacement therapy

Answer

The correct chronological sequence is: 1) Obtain a urine beta-hCG test, 2) Perform a pelvic ultrasonography, 3) Measure serum testosterone and obtain a karyotype, 4) Perform bilateral laparoscopic gonadectomy, and 5) Initiate estrogen replacement therapy.
The correct chronological sequence follows the standardized algorithmic approach to primary amenorrhea: always rule out pregnancy first, establish the presence or absence of a uterus via ultrasound, and then pursue specific endocrine and genetic testing based on the anatomical findings. Finally, the sequence culminates in the appropriate surgical and medical management of Complete Androgen Insensitivity Syndrome (CAIS).

Step-by-Step Solution

1
Order a urine beta-hCG test.
Rules out pregnancy.
Pregnancy is the most common cause of amenorrhea and must be excluded in all reproductive-age females before any further workup.
2
Perform pelvic ultrasonography.
Identifies the presence or absence of internal müllerian structures.
Guides the algorithm toward either an anatomical outflow tract issue or a genetic/endocrine etiology.
3
Measure serum testosterone and obtain a karyotype.
Confirms a 46,XY karyotype with male-range testosterone.
Differentiates Complete Androgen Insensitivity Syndrome from Müllerian agenesis in a patient with an absent uterus and normal breast development.
4
Perform bilateral laparoscopic gonadectomy.
Removes the cryptorchid testes.
Prevents malignant transformation (e.g., dysgerminoma), which is indicated after the completion of pubertal breast development.
5
Initiate estrogen replacement therapy.
Provides necessary hormonal support.
Maintains bone density and secondary sexual characteristics after the endogenous source of aromatized androgens is surgically removed.

Key Concept

Stepwise evaluation of primary amenorrhea and the definitive management of Complete Androgen Insensitivity Syndrome (CAIS).
Estimated Time:2m 0s
Rate this question